Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
436.21M | 244.59M | 211.00M | 62.24M | 35.16M | Gross Profit |
116.15M | 51.41M | 18.99M | -1.89M | -11.82M | EBIT |
-189.80M | -177.92M | -135.20M | -102.05M | -54.95M | EBITDA |
-151.80M | -148.78M | -105.26M | -91.20M | -44.59M | Net Income Common Stockholders |
-190.18M | -182.57M | -135.94M | -117.32M | -55.01M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
418.99M | 244.77M | 471.79M | 690.96M | 52.79M | Total Assets |
1.18B | 941.21M | 989.12M | 980.85M | 187.87M | Total Debt |
424.37M | 176.69M | 152.78M | 128.43M | 27.30M | Net Debt |
153.33M | 14.17M | -89.73M | -562.53M | -25.49M | Total Liabilities |
801.89M | 386.67M | 315.92M | 282.40M | 354.58M | Stockholders Equity |
382.45M | 554.54M | 673.21M | 698.45M | -166.71M |
Cash Flow | Free Cash Flow | |||
-115.98M | -153.57M | -148.95M | -97.49M | -52.88M | Operating Cash Flow |
-48.89M | -98.87M | -106.54M | -71.79M | -27.76M | Investing Cash Flow |
-98.33M | 12.02M | -346.08M | -92.13M | -37.33M | Financing Cash Flow |
256.68M | 7.37M | 2.04M | 799.94M | 21.48M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | $1.03B | 29.21 | 5.25% | ― | 3.02% | 95.76% | |
72 Outperform | $7.73B | 142.63 | 3.94% | ― | 5.21% | ― | |
64 Neutral | $4.46B | 11.94 | 5.17% | 249.36% | 4.00% | -12.35% | |
56 Neutral | $12.00B | ― | -45.38% | ― | 64.98% | -10.52% | |
51 Neutral | $947.35M | ― | -451.56% | ― | 1.36% | -213.86% | |
48 Neutral | $167.55M | ― | -95.46% | ― | -34.33% | 52.30% | |
43 Neutral | $1.38B | ― | -148.98% | ― | ― | -2.94% |
On May 8, 2025, Rocket Lab USA announced a holding company reorganization to be effective by June 1, 2025, aiming to create a more efficient structure for growth and risk management. This reorganization will involve a tax-free merger, with Rocket Lab Corporation becoming the successor issuer, and is expected to streamline operations and align with U.S. Government security requirements. Additionally, Rocket Lab reported strong financial results for Q1 2025, with a 32% year-on-year revenue growth to $123 million, and provided a positive outlook for Q2 2025, highlighting its resilience and strategic expansions into new markets and acquisitions.
On March 11, 2025, Rocket Lab USA announced the filing of a prospectus supplement with the SEC for an ‘at the market’ equity offering program, allowing the company to offer and sell up to $500 million in common stock. The proceeds are intended to fund future growth, including potential acquisitions like the announced intent to acquire Mynaric, and for general corporate purposes. This move is expected to impact Rocket Lab’s operations by providing financial flexibility for expansion and strategic acquisitions, potentially enhancing its position in the space industry.